Developer docs
API playgroundTry for free, no card

Search company profiles

Decisive Consulting

Full company profile

uuid003knim

Namestring
Decisive Consulting
Legal namestring
Decisive Consulting Ltd.
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Decisive Consulting is a London-headquartered life sciences consultancy founded in 2020 by Esther Nzenza, specializing in market access strategy, health economics and outcomes research (HEOR), HTA preparation, pricing and reimbursement strategy, and launch planning for pharmaceutical and biotechnology clients. The firm operates through a set of branded service modules — LIFT (early evidence planning), TRANSFORM (launch strategy), EVIDENCE (HEOR), and VALUATE (pricing/reimbursement) — underpinned by a proprietary "Rebel Thinking" methodology that emphasizes creative problem-solving in challenging reimbursement environments. Decisive has supported more than 45 companies since inception, serving enterprise pharma (including top-10 pharma) and biotech clients across oncology, rare disease, biosimilars, and general medicine.

Decisive monetizes through project-based consulting engagements delivered by senior consultant-led teams directly to enterprise clients, with no publicly disclosed pricing. The firm has productized certain capabilities via PICO Predict, an AI-enabled PICO extraction tool built on GPT-4 that processes over 680,000 clinical trial abstracts with reported 98% completeness and 92.4% accuracy, and JCA-Lab, a coordinated service bundle developed with the Herspiegel group for EU Joint Clinical Assessment preparation.

In June 2025, Herspiegel acquired Decisive, with founder Esther Nzenza transitioning to Senior Partner Global Value and Market Access. In April 2026, Decisive merged with Herspiegel, Adivo Associates, FIECON, and Sixsense Strategy Group to form Acumetis, a 350+ expert, 50+ market global life sciences commercialization platform backed by DFW Capital. Decisive now operates as part of the Acumetis brand, with its original website redirecting to Acumetis.

Short descriptiontext

Decisive Consulting is a London-based life sciences consultancy providing market access, HEOR, HTA, pricing, and launch strategy services to pharmaceutical and biotechnology companies, now operating as part of the Acumetis platform following the 2026 merger.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical market access, health economics consulting, HTA strategy services, life sciences commercialization, biotech pricing reimbursement
Industry1 code
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting
NAICS code2 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Market Access Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Strategic Consulting Services
TypeProfessional Services
Description

Project-based consulting engagements providing market access strategy, health economics, HTA strategy, and commercialization support to pharmaceutical and biotech companies throughout the product lifecycle.

teamdecisive.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Decisive Consulting is a specialist life sciences market access and commercialization consultancy that advises pharmaceutical and biotech companies on strategy, evidence, and execution across the product lifecycle. Engagements cover market access, HTA strategy and submission, health economics and outcomes research, pricing and reimbursement, launch planning, and capability building, organized around four named service modules—LIFT, TRANSFORM, EVIDENCE, and VALUATE—and delivered alongside proprietary AI-enabled tools such as PICO Predict and the JCA-Lab service suite for EU Joint Clinical Assessment preparation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Breakthrough access results even in challenging circumstances
+2 more records
Product overview1 text field

Decisive Consulting is a life sciences market access consultancy that operates as part of the Acumetis global network (following a 2025 acquisition by Herspiegel and subsequent 2026 merger into Acumetis). The firm offers a portfolio of interconnected consulting services organized around four core modules—LIFT (early evidence planning), TRANSFORM (launch strategy), EVIDENCE (HEOR and value demonstration), and VALUATE (pricing and reimbursement)—supported by proprietary AI-enabled tools including PICO Predict (for JCA PICO prediction) and JCA-Lab (for JCA preparation services). The firm's 'Rebel Thinking' methodology underpins all engagements, emphasizing creative problem-solving for breakthrough market access results.

Product and service6 records
1PICO Predict
CategoryAI Tool / Software Service
Description

AI-enabled solution that assists pharmaceutical and medical device companies in preparing for the European Union's Joint Clinical Assessment (JCA) process by predicting PICO (Population, Intervention, Comparator, Outcomes) elements from clinical trial literature to support early PICO scoping.

2JCA-Lab
CategoryJCA Preparation Services
Description

A range of services brought together by the Herspiegel group of companies (including Decisive and FIECON) to help pharmaceutical, biotech, and ATMP developer companies prepare for and implement Joint Clinical Assessments under EU HTA regulation.

3LIFT
CategoryMarket Access Consulting Module
Description

Strategic advisory service within Decisive's core offering focused on early evidence planning and development strategy for pharmaceutical and biotech clients preparing assets for market access.

4TRANSFORM
CategoryMarket Access Consulting Module
Description

Market access transformation service within Decisive's core offering focused on strategic planning and execution support for product launches across European and international markets.

5EVIDENCE
CategoryHEOR Consulting Module
Description

Health economics and outcomes research (HEOR) service within Decisive's core offering focused on evidence generation and value demonstration for HTA and payer submissions.

6VALUATE
CategoryPricing and Reimbursement Consulting Module
Description

Pricing and reimbursement strategy service within Decisive's core offering focused on valuation, pricing corridors, and market access negotiations with payers.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-23
Description

Herspiegel acquired Decisive Consulting in June 2025, integrating Decisive's global market access focused 'Rebel Thinking' with Herspiegel's world-class commercialization services. Decisive Founder Esther Nzenza became Senior Partner Global Value and Market Access at Herspiegel.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-11-18
Description

Decisive Consulting and uMed announced a partnership to drive data-driven market access success in Cardiometabolic and Parkinson's Disease research. The collaboration offers pharmaceutical and biotech companies rapid access to unique, customizable data and expert guidance to bridge HTA evidence gaps.

3Links Life Sciences
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership providing access to industry specialists and expertise in life sciences consulting.

teamdecisive.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership providing access to industry specialists and consulting expertise.

5WODA Alliance
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership providing access to industry specialists and consulting expertise.

teamdecisive.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Decisive Consulting

Pharmaceutical Market Access Consultingteamdecisive.com

Decisive Consulting is a London-based life sciences consultancy providing market access, HEOR, HTA, pricing, and launch strategy services to pharmaceutical and biotechnology companies, now operating as part of the Acumetis platform following the 2026 merger.

What Decisive Consulting does

Decisive Consulting is a London-headquartered life sciences consultancy founded in 2020 by Esther Nzenza, specializing in market access strategy, health economics and outcomes research (HEOR), HTA preparation, pricing and reimbursement strategy, and launch planning for pharmaceutical and biotechnology clients. The firm operates through a set of branded service modules — LIFT (early evidence planning), TRANSFORM (launch strategy), EVIDENCE (HEOR), and VALUATE (pricing/reimbursement) — underpinned by a proprietary "Rebel Thinking" methodology that emphasizes creative problem-solving in challenging reimbursement environments. Decisive has supported more than 45 companies since inception, serving enterprise pharma (including top-10 pharma) and biotech clients across oncology, rare disease, biosimilars, and general medicine.

Decisive monetizes through project-based consulting engagements delivered by senior consultant-led teams directly to enterprise clients, with no publicly disclosed pricing. The firm has productized certain capabilities via PICO Predict, an AI-enabled PICO extraction tool built on GPT-4 that processes over 680,000 clinical trial abstracts with reported 98% completeness and 92.4% accuracy, and JCA-Lab, a coordinated service bundle developed with the Herspiegel group for EU Joint Clinical Assessment preparation.

In June 2025, Herspiegel acquired Decisive, with founder Esther Nzenza transitioning to Senior Partner Global Value and Market Access. In April 2026, Decisive merged with Herspiegel, Adivo Associates, FIECON, and Sixsense Strategy Group to form Acumetis, a 350+ expert, 50+ market global life sciences commercialization platform backed by DFW Capital. Decisive now operates as part of the Acumetis brand, with its original website redirecting to Acumetis.

Decisive Consulting firmographics

Firmographics
Name
Decisive Consulting
Legal name
Decisive Consulting Ltd.
Website
https://teamdecisive.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Decisive Consulting is a London-based life sciences consultancy providing market access, HEOR, HTA, pricing, and launch strategy services to pharmaceutical and biotechnology companies, now operating as part of the Acumetis platform following the 2026 merger.
Ownership category
akta.pro rank

Decisive Consulting industry classification

Industry
Product category
Pharmaceutical Market Access Consulting
NAICS
Management Consulting Services (54161), Other Management Consulting Services (541618)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting

Keywords

  • Pharmaceutical market access
  • Health economics consulting
  • HTA strategy services
  • Life sciences commercialization
  • Biotech pricing reimbursement

Where Decisive Consulting is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Decisive Consulting business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Strategic Consulting Services: Project-based consulting engagements providing market access strategy, health economics, HTA strategy, and commercialization support to pharmaceutical and biotech companies throughout the product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Decisive Consulting product offering

Product offering

Core offering

Decisive Consulting is a specialist life sciences market access and commercialization consultancy that advises pharmaceutical and biotech companies on strategy, evidence, and execution across the product lifecycle. Engagements cover market access, HTA strategy and submission, health economics and outcomes research, pricing and reimbursement, launch planning, and capability building, organized around four named service modules—LIFT, TRANSFORM, EVIDENCE, and VALUATE—and delivered alongside proprietary AI-enabled tools such as PICO Predict and the JCA-Lab service suite for EU Joint Clinical Assessment preparation.

Product overview

Decisive Consulting is a life sciences market access consultancy that operates as part of the Acumetis global network (following a 2025 acquisition by Herspiegel and subsequent 2026 merger into Acumetis). The firm offers a portfolio of interconnected consulting services organized around four core modules—LIFT (early evidence planning), TRANSFORM (launch strategy), EVIDENCE (HEOR and value demonstration), and VALUATE (pricing and reimbursement)—supported by proprietary AI-enabled tools including PICO Predict (for JCA PICO prediction) and JCA-Lab (for JCA preparation services). The firm's 'Rebel Thinking' methodology underpins all engagements, emphasizing creative problem-solving for breakthrough market access results.

Differentiator

Problem solved

Functional benefit

Products and services

  • PICO Predict AI-enabled solution that assists pharmaceutical and medical device companies in preparing for the European Union's Joint Clinical Assessment (JCA) process by predicting PICO (Population, Intervention, Comparator, Outcomes) elements from clinical trial literature to support early PICO scoping.
  • JCA-Lab A range of services brought together by the Herspiegel group of companies (including Decisive and FIECON) to help pharmaceutical, biotech, and ATMP developer companies prepare for and implement Joint Clinical Assessments under EU HTA regulation.
  • LIFT Strategic advisory service within Decisive's core offering focused on early evidence planning and development strategy for pharmaceutical and biotech clients preparing assets for market access.
  • TRANSFORM Market access transformation service within Decisive's core offering focused on strategic planning and execution support for product launches across European and international markets.
  • EVIDENCE Health economics and outcomes research (HEOR) service within Decisive's core offering focused on evidence generation and value demonstration for HTA and payer submissions.
  • VALUATE Pricing and reimbursement strategy service within Decisive's core offering focused on valuation, pricing corridors, and market access negotiations with payers.

Quantifiable outcome

  • Breakthrough access results even in challenging circumstances
  • +2 more outcomes

Companies that use Decisive Consulting

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Decisive Consulting technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature2 records

Decisive Consulting partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • HerspiegelcoreStrategic or Co-development Partner · 23 June 2025Herspiegel acquired Decisive Consulting in June 2025, integrating Decisive's global market access focused 'Rebel Thinking' with Herspiegel's world-class commercialization services. Decisive Founder Esther Nzenza became Senior Partner Global Value and Market Access at Herspiegel.
  • uMedminorStrategic or Co-development Partner · 18 November 2024Decisive Consulting and uMed announced a partnership to drive data-driven market access success in Cardiometabolic and Parkinson's Disease research. The collaboration offers pharmaceutical and biotech companies rapid access to unique, customizable data and expert guidance to bridge HTA evidence gaps.
  • Links Life SciencesminorStrategic or Co-development PartnerStrategic partnership providing access to industry specialists and expertise in life sciences consulting.
  • Prime MoverminorStrategic or Co-development PartnerStrategic partnership providing access to industry specialists and consulting expertise.
  • WODA AllianceminorStrategic or Co-development PartnerStrategic partnership providing access to industry specialists and consulting expertise.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Decisive Consulting competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Decisive Consulting social profiles

Digital presence

Decisive Consulting financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Decisive Consulting leadership team

Management profile

Number of profiles

Profiles1 record

Decisive Consulting funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Decisive Consulting M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Decisive Consulting

What does Decisive Consulting do?

Decisive Consulting is a specialist life sciences market access and commercialization consultancy that advises pharmaceutical and biotech companies on strategy, evidence, and execution across the product lifecycle. Engagements cover market access, HTA strategy and submission, health economics and outcomes research, pricing and reimbursement, launch planning, and capability building, organized around four named service modules—LIFT, TRANSFORM, EVIDENCE, and VALUATE—and delivered alongside proprietary AI-enabled tools such as PICO Predict and the JCA-Lab service suite for EU Joint Clinical Assessment preparation.

Is Decisive Consulting a public or private company?

Decisive Consulting is a private company. It is classified as private equity controlled and is currently operating.

When was Decisive Consulting founded?

Decisive Consulting was founded in 2020. It employs 11 to 50 people.

Where is Decisive Consulting based?

Decisive Consulting is headquartered in London, United Kingdom, in the Europe region.

How does Decisive Consulting make money?

One revenue line is on record: strategic Consulting Services.

Does Decisive Consulting have an API?

No public API is recorded for Decisive Consulting.

What industry is Decisive Consulting in?

Decisive Consulting's product category is Pharmaceutical Market Access Consulting. Its primary akta.pro industry code is BPAHACAA, Strategy & Corporate Development Consulting. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals